Details of the Drug Formulaction

General Information of Drug Formulation (ID: F12683)

Formulation Name
Loxapine 50 mg capsule
Company
Actavis Pharma; Clinical Solutions Wholesale; RemedyRepack
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Loxapine DM8AI9U Bipolar disorder 6A60 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Benzyl alcohol E00010 244 Antimicrobial preservative; Solvent
Beta-D-lactose E00099 6134 Diluent; Dry powder inhaler carrier; Lyophilization aid
Butylparaben E00142 7184 Antimicrobial preservative
Edetate calcium disodium E00487 6093170 Complexing agent
FD&C blue no. 1 E00263 19700 Colorant
Magnesium stearate E00208 11177 lubricant
methylparaben E00149 7456 Antimicrobial preservative
Propyl 4-hydroxybenzoate E00141 7175 Antimicrobial preservative
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sodium propionate E00445 2723816 Antimicrobial preservative
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent